In this state of advanced insulin resistance, the decrease in insulin lowers PI3K/AKT signaling and increases FoxO1 activity which impairs PDX1-mediated β-cell growth further reducing insulin secretion and contributing to T2D pathogenesis. The gene discussed is FOXO1; the disease is Insulin resistance.